TP53 Y220C mutations in patients with myeloid malignancies. - Gener-Ricos G; Bewersdorf JP; Loghavi S; Bataller A; Goldberg AD; Sasaki K; Famulare C; Takahashi K; Issa GC; Borthakur G; Kadia TM; Short NJ; et al. (Leukemia & lymphoma, 2024)